Hostile bids in the Pharmaceutical sector are rarer than hen’s teeth. So rare in fact that only one comes readily to mind, Pfizer’s (NYSE: PFE) $90 billion acquisition of Warner-Lambert in mid-2000. And even then, what began as a hostile bid in late 1999 turned...
Merger and acquisition activity in the health care industry remained relatively steady during the fourth quarter of 2003. With a total of 221 deals announced, Q4:03 registered just a 4% dip against the 230 transactions announced in the previous quarter (Q3:03). Deal...
Merger and acquisition activity in the health care industry was brisk in 2003. We estimate the year will close with 875 deals which, based on prices revealed to date, are collectively worth $90 billion. These figures receded somewhat from last year’s levels. The year...
On the last Monday in October, the Managed Care sector produced two of the largest deals to be announced in the past 10 years. Even news on the same day of the $48 billion merger of Bank of America (NYSE: BAC) and FleetBoston Financial Corp. (NYSE: FBF) could not take...
Results are in for the health care M&A market during the third quarter of 2003. Reflecting a gradual improvement in the overall economy during the most recent quarter, both deal volume and the amount spent to finance this acquisition activity showed an increase...
Containing spiraling drug costs has been on everyone’s mind, from Congress to the everyday consumer. While one wag quipped that Ashcroft’s office may be studying the movie “Canadian Bacon” in preparation for a raid on the Great White North to staunch the...